Core Viewpoint - Meirui Health International (02327.HK) announced the acquisition of 100% equity in Jiangsu Yide for a total consideration of RMB 125 million (approximately HKD 137 million) [1] Group 1: Acquisition Details - The acquisition agreement was signed on January 8, 2026, between Meirui Health International (as the buyer) and Yuye Group and Tan Wensheng (as the sellers) [1] - Jiangsu Yide is a limited liability company established in China, primarily engaged in equity investment and property leasing [1] - Following the completion of the acquisition, Jiangsu Yide will become a wholly-owned subsidiary of Meirui Health International, and its financial performance will be consolidated into the group's financial statements [1] Group 2: Shareholding Structure - Jiangsu Yide is currently owned by Yuye Group and Tan Wensheng, holding 40% and 60% of the equity, respectively [1] - A personal guarantee was provided by Zhou Xuzhou to ensure the sellers fulfill their obligations under the equity transfer agreement [1]
美瑞健康国际(02327.HK)拟收购江苏懿德全部股权 作价1.25亿元